Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues

Neuroendocrinology

Volumn 88, Issue 2, 2008, Pages 135-146

  Sattin, Albert ^a,b   Pekary, Albert E ^a,b   Blood, James ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epididymis; Escitalopram; Limbic system; Thyrotropin releasing hormone

Indexed keywords

ESCITALOPRAM; NEUROTRANSMITTER; PROTIRELIN; PROTIRELIN DERIVATIVE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOOD; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT;

ANIMALS; BRAIN; CITALOPRAM; CORTICOSTERONE; DISSECTION; EPIDIDYMIS; MALE; ORGAN SIZE; PEPTIDE FRAGMENTS; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS; TESTIS; THYROTROPIN-RELEASING HORMONE; TIME FACTORS; TISSUE DISTRIBUTION; TISSUE EXTRACTS;

EID: 50649096598     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121595     Document Type: Article

References (62)

1. Chattopadhyay A (ed): Serotonin Receptors in Neurobiology. CRC Press, New York, 2007.
2. Deutch AY, Roth RH: Neurotransmitters; in Zigmond MJ, Bloom FE, Landis SC, Roberts JL, Squire LR (eds): Fundamental Neuroscience. San Diego, Academic Press, 1999, chap 8, pp 193-234.
3. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS: Reduced brain serotonin transporter availability in major depression as measured by 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 1998;44:1090-1098.
4. Torres GE, Gainetdinov RR, Caron MG: Plasma membrane monoamine transporters: structure, regulation and function. Nature Rev Neurosci 2003;4:13-25.
5. Hyttel J, Arnt J, Sanchez C: The pharmacology of citalopram. Rev Contemp Pharmacother 1995;6:271-285.
6. Stahl SM: Not so selective serotonin re-uptake inhibitors. J Clin Psychiatry 1998;59:343-344.
7. Uys JDK, Muller CJF, Marais L, Harvey BH, Stein DJ, Daniels WMU: Early life trauma decreases glucocorticoid receptors in rat dentate gyrus upon adult re-stress: reversal by escitalopram. Neuroscience 2006;137:619-625.
8. Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjodin I, Penttinen JT, Pedersen T, Lehto HJ: A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry 1998;59:528-534.
9. Wade AG, Lepola U, Koponen HJ: The effect of citalopram in panic disorder. Br J Psychiatry 1997;170:549-553.
10. Fish EW, Faccidomo S, Gupta S, Miczek KA: Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups. J Pharmacol Exp Ther 2004;308:474-480.
11. Lenze EJ, Mulsant BH, Shear MK, Dew MA, Miller MD, Pollock BG, Houck P, Tracey B, Reynolds CF 3rd: Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry 2005;162:146-150.
12. Montgomery SA, Nil R, Durr-Pal N, Loft H, Boulenger JP: A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. J Clin Psychiatry 2005;66:1270-1278.
13. Rygula R, Abumaria N, Flugge G, Hiemke C, Fuchs E, Ruther E, Havemann-Reinecke U: Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav Pharmacol 2006;17:19-29.
14. Strekalova T, Gorenkova N, Schunk E, Dolgov O, Bartsch D: Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol 2006;17:271-287.
15. Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP, Zohar J: World Council of Anxiety. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr 2003;8(suppl 1):7-16.
16. Koponen H, Lepola U, Leinonen E, Jokinen R, Penttinen J, Turlonen J: Citalopram in the treatment of obsessive compulsive disorder: an open pilot study. Acta Psychiatr Scand 1997;96:343-346.
17. Stein DJ, Maud CM, Bouwer C: Use of the selective serotonin reuptake inhibitor citalopram in obsessive-compulsive disorder. J Serotonin Res 1996;1:29-33.
18. Nyth AL, Gottfries CG: The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multi-centre study. Br J Psychiatry 1990;157:894-901.
19. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF: The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-552.
20. Andersen G, Vestergaard K, Riis Jens O: Citalopram for post-stroke pathological crying. Lancet 1993;342:837-839.
21. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, Eriksson E: Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychophormacol 1998;18:390-398.
22. 2 (EEP) in rat brain. Peptides 1999;20:107-119.
23. Pekary AE, Meyerhoff JL, Sattin A: Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum. Brain Res 2000;884:174-183.
24. Pekary AE, Senanayake S, Sattin A: Cocaine regulates TRH-related peptides in rat brain. Neurochem Int 2002;41:415-428.
25. Pekary AE, Sattin A, Meyerhoff JL, Chilingar M: Valproate modulates TRH receptor, TRH and TRH-like peptide levels in rat brain. Peptides 2004;25:647-658.
26. Pekary AE, Faull KF, Paulson M, Lloyd RL, Sattin A: TRH-like antidepressant peptide, pyroglutamyltyrosylprolineamide, occurs in rat brain. J Mass Spectr 2005;40:1232-1236.
27. Pekary AE, Stevens SA, Sattin A: Rapid modulation of TRH and TRH-like peptide levels in rat brain and peripheral tissues by corticosterone. Neurochem Int 2006;48:208-217.
28. Pekary AE, Stevens SA, Sattin A: Valproate and copper accelerate TRH-like peptide synthesis in male rat pancreas and reproductive tissues. Peptides 2006;27:2901-2911.
29. Pekary AE, Stevens SA, Sattin A: Circadian rhythms of TRH-like peptide levels in rat brain. Brain Res 2006;1125:67-76.
30. Pekary AE, Sattin A, Stevens SA: Rapid modulation of TRH-like peptides in rat brain by thyroid hormones. Peptides 2006;27:1577-1588.
31. Pekary AE, Stevens SA, Sattin A: Lipopolysaccharide modulation of thyrotropin-releasing hormone (TRH) and TRH-like peptide levels in rat brain and endocrine organs. J Mol Neurosci 2007;31:245-259.
32. Sattin A: The role of TRH and related peptides in the mechanism of action of ECT. J ECT 1999;15:76-92.
33. Sattin A, Senanayake SS, Pekary AE: Lithium modulates expression of TRH receptors and TRH-related peptides in rat brain. Neuroscience 2002;115:263-273.
34. Zeng H, Schimpf BA, Rohde AD, Pavlova MN, Gragerov A, Bergmann JE: Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol Endocrinol 2007;21:2795-2804.
35. Scalabrino GA, Hogan N, O'Boyle KM, Slator GR, Gregg DJ, Fetchett CM, Draper SM, Bennett GW, Hinkle PM, Bauer K, Williams CH, Topton KF, Kelly JA: Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Neuropharmacology 2007;52:1472-1481.
36. Kachidian P, Poulat P, Marlier L, Privat A: Immunohistochemical evidence for the coexistence of substance P, thyrotropin-releasing hormone, GABA, methionine-enkephalin, and leucin-enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the rat. J Neurosci Res 1991;30:521-530.
37. Ballerini L, Corradetti R, Nistri A, Pugliese AM, Stocca G: Electrophysiological interactions between 5-hydroxytryptamine and thyrotropin releasing hormone on rat hippocampal CA1 neurons. Eur J Neurosci 1994;6:953-960.
38. Przegalinski E, Jaworska L, Golembiowska K: The effect of p-chloroamphetamine and p-chlorophenylalanine on the level of thyrotropin-releasing hormone and its receptors in some brain structures and lumbar spinal cord of the rat. Neuropeptides 1992;23:19-25.
39. Dahm T, White J, Grill S, Fullekrug J, Stelzer EH: Quantitative ER 〈-〉 Golgi transport kinetics and protein separation upon Golgi exit revealed by vesicular integral membrane protein 36 dynamics in live cells. Mol Biol Cell 2001;12:1481-1498.
40. Jimenez-Trejo F, Tapia-Rodriguez M, Queiroz DBC, Padilla P, Avellar MCW, Manzano PR, Manjarrez-Gutierrez G, Gutierrez-Ospina G: Serotonin concentration, synthesis, cell origin, and targets in the rat caput epididymis during sexual maturation and variations associated with adult mating status: morphological and biochemical studies. J Androl 2007;28:136-149.
41. Tinajero JC, Fabbri A, Ciocca DR, Dufau ML: Serotonin secretion from rat Leydig cells. Endocrinology 1993;133:3026-3029.
42. Frungieri MB, Gonzalez-Calvar SI, Rubio M, Ozu M, Lustig L, Calandra RS: Serotonin in golden hamster testes: testicular levels, immunolocalization and role during sexual development and photoperiodic regression-recrudescence transition. Neuroendocrinology 1999;69:299-308.
43. 2C serotonin receptors differentially modulate mouse sexual arousal and the hypothalamo-pituitary-testicular response to the presence of a female. Neuroendocrinology 2002;76:28-34.
44. Pekary AE, Lukaski HC, Mena I, Smith SM, Bhasin S, Hershman JM: Testosterone increases TRH biosynthesis in epididymis but not heart of zinc-deficient rats. Peptides 1993;14:315-324.
45. Parisi E, De Prisco P, Capasso A, del Prete M: Serotonin and sperm motility. Cell Biol Int Reprod 1984;8:95.
46. Fujita T, Iwananga T, Lee SH, Terada M: Sensor cells and nerve terminals in some gut-derived organs: a review. Ital J Anat Embryol 1995;100:197-204.
47. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C: Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann NY Acad Sci 1998;861:204-216.
48. Huska MT, Catalano G, Catalano MC: Serotonin syndrome associated with the use of escitalopram. CNS Spectr 2007;12:270-274.
49. Stahl SM: Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 2000;48:894-901.
50. Pineyro G, Blier P: Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 1999;51:533-591.
51. Bundgaard C, Larsen F, Jorgensen M, Gabrielsson J: Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: Application to escitalopram-induced effects on brain serotonin levels. Eur J Pharmaceut Sci 2006;29:394-404.
52. Bannerman DM, Grubb M, Deacon RM, Yee BK, Feldon J, Rawlins JN: Ventral hippocampal lesions affect anxiety but not special learning. Behav Brain Res 2003;139:197-213.
53. Moser E, Moser MB, Andersen P: Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J Neurosci 1993;13:3916-3925.
54. Aguilar-Valles A, Sanchez E, de Gortari P, Garcia-Vazquez AI, Ramirez-Amaya V, Bermudez-Rattoni F, Joseph-Bravo P: The expression of TRH, its receptors and degrading enzyme is differentially modulated in the rat limbic system during training in the Morris water maze. Neurochem Int 2007;50:404-417.
55. Redei E, Hilderbrand H, Aird F: Corticotropin release-inhibiting factor is preprothyrotropin releasing hormone (178-199). Endocrinology 1995;136:3557-3593.
56. Heinrichs SC, Koob GF: Corticotropin-releasing factor in brain: a role in activation, arousal and affect regulation. J Pharmacol Exp Ther 2004;311:427-440.
57. 2 (EEP), a TRH Analog, Mitigates the Fear Response Typical in Learned Helplessness. Program No. 889.18. Abstract Viewer/Itinerary Planner. Washington, Society for Neuroscience, 2005.
58. Bastian AJ: Learning to predict the future: the cerebellum adapts feedforward movement control. Curr Opin Neurobiol 2006;16:645-649.
59. Bonne O, Drevets WC, Neumeister A, Charney DS: Chapter 47. Neurobiology of anxiety disorders; in Schatzber AF, Nemeroff CB (eds): Textbook of Psychopharmacology, ed 3. Arlington, American Psychiatric Publishing, 2004, pp 775-792.
60. Price ML, Lucki I: Regulation of serotonin release in the lateral septum and striatum by corticotrophin-releasing factor. J Neurosci 2001;21:2833-2841.
61. Kirby LG, Lucki I: The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat. Stress 1998;2:251-263.
62. Kosten TA, Zhang XY, Kohoe P: Infant rats with chronic neonatal isolation experience show decreased extracellular serotonin levels in ventral striatum at baseline and in response to cocaine. Brain Res Dev Brain Res 2004;152:19-24.